002693.SZ · 双成药业
China A-shares · RS rating 92 · As of 2026-10-14
| Price | 9.77 CNY |
|---|---|
| 1-day change | -5.3% |
| RS rating (overall / 1M / 3M / 12M) | 92 / 94 / 57 / 87 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 45 / 55 / 40 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +41.9% |
| Distance from 52-week high | +15.8% |
| Market cap (USD) | $607.8M |